Target intelligence / Profile preview

Nuclear factor, erythroid 2 like 3 pseudogene 1 (NFE2L3P1)

Target
NFE2L3P1
Molecular classification
Other (Pseudogene)
01

Overview

Nuclear factor, erythroid 2 like 3 pseudogene 1 (NFE2L3P1) is annotated as a *pseudogene* in the human genome, related by sequence similarity to the functional gene NFE2L3 (Nuclear factor, erythroid 2 like 3) but lacking evidence for protein expression or biological function. Pseudogenes are segments of DNA similar to known genes but generally non-functional due to mutations, deletions, or truncations that prevent their expression as proteins. Unlike NFE2L3, which is a transcription factor belonging to the CNC-bZIP family and involved in cancer and cellular homeostasis[2], NFE2L3P1 does not function as a receptor, enzyme, transcription factor, or any other therapeutic target class. There is no evidence that NFE2L3P1 interacts with drugs, acts as a biomarker, or is associated with disease biology. Its inclusion in target lists is likely due to nomenclature confusion or incomplete curation.\n\nNote:\nIf you intended to refer to *NFE2L3* (\"Nuclear factor, erythroid 2 like 3\"), this is a functional transcription factor involved in cell cycle, cancer, and stress responses[2], but *NFE2L3P1* is a pseudogene. This makes NFE2L3P1 *incorrect* as a therapeutic target or receptor.

Other names
NFE2L3P1
02

Mechanism of action

Null (No mechanism, not a target)

03

Biological functions

Null (Pseudogene; no known biological function)
04

Disease associations

Null (No known disease role)
05

Safety considerations

Null (No safety concerns relevant for therapy)
06

Interacting drugs

Null (No known drug interactions)
07

Biomarkers

Null (Not used as a biomarker)

Beyond the preview

Go deeper on Nuclear factor, erythroid 2 like 3 pseudogene 1 (NFE2L3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor, erythroid 2 like 3 pseudogene 1 (NFE2L3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call